DALMASSO, BRUNA SAMIA
 Distribuzione geografica
Continente #
EU - Europa 2.291
AS - Asia 14
NA - Nord America 1
Totale 2.306
Nazione #
IT - Italia 2.291
CN - Cina 8
SG - Singapore 5
TH - Thailandia 1
US - Stati Uniti d'America 1
Totale 2.306
Città #
Genova 992
Genoa 866
Rapallo 269
Vado Ligure 162
Singapore 4
Beijing 2
Bordighera 2
Ashburn 1
Bangkok 1
Cixi 1
Totale 2.300
Nome #
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 214
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients 185
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations 179
Circulating MicroRNAs as easy-to-measure aging biomarkers in older breast cancer patients: Correlation with chronological age but not with fitness/frailty status 159
An open pilot study of zonisamide augmentation in major depressive patients not responding to a low dose trial with duloxetine: Preliminary results on tolerability and clinical effects 154
Age-related microRNAs in older breast cancer patients: Biomarker potential and evolution during adjuvant chemotherapy 154
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide 140
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients 131
The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters 127
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations [Oncotarget. 2018; 9:5691-5702]doi 10.18632/oncotarget.23204 127
Disruption of DNA damage response pathways in tumorigenesis: investigating the role of ATM and BAP1 in hereditary cancers. 126
Biological ageing and frailty markers in breast cancer patients 125
Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1 110
Efficacy of braf and mek inhibition in patients with braf‐mutant advanced melanoma and germline cdkn2a pathogenic variants 86
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility 80
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications 67
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 57
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup 55
Reply to E. Hindié 44
Assessing Determinants of Response to PARP Inhibition in Germline ATM Mutant Melanoma 44
Italian Melanoma Intergroup tele-genetic counseling project for melanoma predisposition syndromes: five-year evaluation of effectiveness and outcomes 13
Totale 2.377
Categoria #
all - tutte 9.300
article - articoli 8.887
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.187


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021148 0 0 0 17 9 13 4 18 16 27 24 20
2021/2022234 15 4 14 25 10 27 8 42 23 30 9 27
2022/2023312 27 33 6 34 46 39 0 36 48 1 36 6
2023/2024153 8 13 2 21 9 18 6 20 6 9 7 34
2024/2025435 7 28 11 35 50 37 35 86 22 27 46 51
2025/2026430 95 32 221 82 0 0 0 0 0 0 0 0
Totale 2.377